Rheumatology

Latest News

digestive tract | Image credit: Aliaksandr Marko - stock.adobe.com
Physician and Patient Perspectives After Starting or Switching to Amgevita in IBD

March 23rd 2024

A real-world study surveying physicians and patients on adalimumab biosimilar ABP 501 (Amgevita) in inflammatory bowel disease (IBD) found both patients initiating ABP 501 and those who had switched from the reference product had higher satisfaction levels.

psorasis | Image credit: SergeVo - stock.adobe.com
AAD Posters Examine Clinical Effects of Switching to Ustekinumab, Adalimumab Biosimilars

March 20th 2024

slow uptake shown with guy riding snail | Image credit: Nuthawut - stock.adobe.com
Webinar Addresses Solutions to Improve Adalimumab Biosimilar Uptake

March 18th 2024

globe health care | Image credit: Planetz - stock.adobe.com
Adalimumab Expenditures in Countries With and Without Available Biosimilars

March 16th 2024

prefilled syringes | Image credit: SOPONE - stock.adobe.com
Posters From AMCCBS and AAD Showcase New Technology for Biosimilar Uptake, Barriers to Self-Injectable Biologics

March 14th 2024

Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.